Srikumar Sahasranaman
4PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 26, 2025
Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model-Based Approach.Ahsan Rizwan, Hugh Giovinazzo, Tian Yu
|Mar 22, 2024
Clinical dose rationale of tislelizumab in patients with solid or hematological advanced tumors.Tian Yu, Xiangyu Liu, Chi-Yuan Wu
|Mar 27, 2021
The pharmacokinetics of pamiparib in the presence of a strong CYP3A inhibitor (itraconazole) and strong CYP3A inducer (rifampin) in patients with solid tumors: an open-label, parallel-group phase 1 study.Song Mu, Chester Lin, Anna Skrzypczyk-Ostaszewicz
|Dec 27, 2019
Effect of rifampin and itraconazole on the pharmacokinetics of zanubrutinib (a Bruton's tyrosine kinase inhibitor) in Asian and non-Asian healthy subjects.Song Mu, Zhiyu Tang, William Novotny
Pageof 1
Frequent Collaborators
2 joint publications
Tian Yu
2 joint publications
Yuying Gao
2 joint publications
Nageshwar Budha
1 joint publications
Xiangyu Liu
1 joint publications
Chi-Yuan Wu
1 joint publications
Zhiyu Tang
1 joint publications
Hongwei Wang
1 joint publications
Patrick Schnell
1 joint publications
Ya Wan
1 joint publications
Kun Wang
